Skip to main content
Equibles
CON logo

CON · Concentra Group Holdings Parent, Inc.

Track CON — free

Use CON with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CON

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$35.43 +0.31 (+0.88%) At close · Aug 14
Market Cap
$4.52B
Shares
127.52M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$35.43 Open$34.91 Day$34.90–35.52 52W close$18.71–35.43 Avg vol 30d946K Short int3.1M · 2.5% float · 4.0d Short vol46% Last earningsAug 7, 2026 DataJul 2024–Aug 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 6, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Fair Quant / Vol Moderate
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +47%
      above
      Price vs 50-day avg +16%
      above
      RSI (14) 71
      overbought
      MACD trend Positive
      52-week position 100%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +12%
      trailing
      6-month return +51%
      trailing
      YTD return +80%
      this year
      Relative strength +38%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $31 › 200d $24 — 50d above 200d
      Institutional flow Accumulating
      +1% holders QoQ · +54 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      2.46% of float · ▼ -7.4% MoM · 4.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      283 holders — near 2-yr high, broad support
      Squeeze score 58
      elevated · 0–100
      Fundamentals
      Fair
      Revenue growth +14%
      Y/Y
      EPS growth −11%
      Y/Y
      Free cash flow $197.1M
      Valuation P/E 22.9
      rich
      Buyback $54.1M
      remaining
      Balance sheet $1.5B
      net debt
      Quant / Vol
      risk profile
      Moderate
      Volatility 29%
      annualized · 1-yr
      Max drawdown −21%
      past year
      ATR 3.2%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Jun 30, 2026
      Free cash flow · full year at least $200M
      Prior guidance period ended · from the 8-K filed Jan 12, 2026
      Revenue · FY 2025 $2.15B – $2.16B
      Adjusted EBITDA · FY 2025 $425M – $430M
      Guided vs delivered · last 1 settled
      Revenue full year 2025
      guided $2.15B – $2.16B
      $2.16B Beat +0.5%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 2 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +47% Bullish
      Price vs 50-day avg
      +16% Bullish
      RSI (14)
      71 Bearish
      MACD trend
      Positive Bullish
      52-week position
      100% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $31 › 200d $24 — 50d above 200d
      Institutional flow Accumulating
      +1% holders QoQ · +54 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      2.46% of float · ▼ -7.4% MoM · 4.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      283 holders — near 2-yr high, broad support
      Price context
      position in its 52-week range
      Range low $19 Now $35 · 100% Range high $35
      vs 200-day avg +47% vs 50-day avg +16%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted Earnings per Share non-GAAP $0.92 Six Months Ended June 30, 2026 —
      GAAP → non-GAAP reconciliation
      GAAP Net Income 205.6M
      +61.93M Income Tax Expense
      +107.28M Interest Expense (Income)
      +0K Loss on Early Retirement of Debt
      +14.2M Stock Compensation Expense
      +79.75M Depreciation and Amortization
      +5.27M Separation Transaction Costs
      +1.78M Nova and Pivot Onsite Innovations Acquisition Costs
      = Adjusted EBITDA 475.81M
      Adjusted EBITDA Margin non-GAAP 22.3% Six Months Ended June 30, 2026 —
      Avg. # of patients cared for each business day 54K TTM June 30, 2026 —
      Business days 127 Six Months Ended June 30, 2026 —
      Capital Expenditures $15.7M Q2 2026 —
      Employer customers 200K TTM June 30, 2026 —
      Employer Services RPV $96 Q2 2026 —
      Employer Services VPD 29.9K Q2 2026 —
      GAAP → non-GAAP reconciliation
      GAAP Net Cash Provided by Operating Activities 336M
      -70M Net Cash Used in Investing Activities
      +4M Business Combinations, Net of Cash Acquired
      = Free Cash Flow 270M
      Free Cash Flow Conversion non-GAAP 131% TTM June 30, 2026 —
      Number of occupational health centers—end of period 633 Six Months Ended June 30, 2026 —
      Number of onsite health clinics—end of period 415 Six Months Ended June 30, 2026 —
      Number of patient visits - Total 7,030,025 Six Months Ended June 30, 2026 —
      Quarterly dividend $0.06 Q2 2026 —
      Return on invested capital non-GAAP 15% TTM June 30, 2026 —
      Revenue per Visit ("RPV") $153 Q2 2026 —
      Revenue per visit - Total $152.67 Three Months Ended June 30, 2026 —
      ROIC non-GAAP 14.6% TTM June 30, 2026 —
      States with service offerings 46 As of June 30, 2026 —
      Total colleagues & affiliated clinicians 13K As of June 30, 2026 —
      TTM Adjusted EBITDA non-GAAP $476M TTM June 30, 2026 —
      TTM Adjusted EBITDA margin non-GAAP 21% TTM June 30, 2026 —
      TTM FCF conversion (FCF / net income) non-GAAP 131% TTM June 30, 2026 —
      TTM Free Cash Flow (FCF) non-GAAP $270M TTM June 30, 2026 —
      Visits per Day ("VPD") 56.4K Q2 2026 —
      Visits per day volume - Total 55,355 Six Months Ended June 30, 2026 —
      Weighted average share price $25.82 Q2 2026 —
      Workers' Compensation RPV $219 Q2 2026 —
      Workers' Compensation VPD 25.8K Q2 2026 —
      Patient visits per day 53,124 FY 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Care Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      CON
      Concentra Group Holdings Parent, Inc.
      this stock
      		$4.52B +80.0% +13.9% 22.9 2.5%
      HCA
      HCA Healthcare, Inc.
      		 $89.77B -13.3% +7.1% 13.9 2.7%
      FSNUY
      Fresenius SE & Co. KGaA
      		 $30.87B -4.4% — — 0.0%
      THC
      Tenet Healthcare Corp
      		 $21.57B +34.8% +0.9% 10.3 4.0%
      FMS
      Fresenius Medical Care AG
      		 $12.65B -0.2% +5.9% — 0.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      283
      % held
      87.2%
      Net QoQ
      +3.3M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      318
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      3.1M
      Days to cover
      4.0d
      Change
      -250.2K sh
      View
      Short Volume
      Short vol %
      46%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      89
      Value
      $2.8K
      As of
      Jul 10, 2026
      View
      Off-Exchange
      Off-exchange %
      44.1%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Lisa McClain
      Amount
      $1.0K–$15.0K
      Traded
      Sep 25, 2025
      View
      Financials
      Financials
      Revenue (FY)
      $2.2B
      Net income (FY)
      $166.4M
      EPS diluted
      $1.30
      View
      Buybacks
      Authorized
      $100.0M
      Remaining
      $54.1M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 6, 2026
      This year
      12
      View
      Proposed Sales
      Value
      $4.1M
      Shares
      130.0K
      Filed
      Aug 3, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 7, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      CON +4.0% +12.1% +51.5% +11.9% +80.0%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY +3.6% +7.6% +37.7% +8.0% +66.2%

      Capital returns

      Latest dividend
      $0.063 / share · ex May 19, 2026
      Declared · upcoming
      $0.0625 / share · ex Aug 20, 2026
      Paid (TTM)
      $0.252 / share · 4 payouts
      Dividend yield (TTM, derived)
      0.71%
      Buyback program · as of Jun 30, 2026
      Authorized
      $100.00M
      Spent (derived)
      $45.90M
      Remaining
      $54.10M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 2014596 CUSIP 20603L102 13F (30d) 266 filings 264 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)